首页> 外国专利> New Corynebacterium glutamicum GTP cyclohydrolase I, dihydropteroate synthase, dihydroneopterin aldolase and 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase polypeptides

New Corynebacterium glutamicum GTP cyclohydrolase I, dihydropteroate synthase, dihydroneopterin aldolase and 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase polypeptides

机译:谷氨酸棒杆菌新的GTP环水解酶I,二氢蝶呤合酶,二氢蝶呤醛缩酶和2-氨基-4-羟基-6-羟甲基-二氢蝶呤焦磷酸激酶多肽

摘要

Corynebacterium glutamicum GTP cyclohydrolase I, dihydropteroate synthase, dihydroneopterin aldolase and 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase polypeptides, are new. The following polypeptides are new: (i) a polypeptide with GTP cyclohydrolase I activity having a defined sequence of 202 amino acids given in the specification, optionally with one or more amino acid deletions, insertions or substitutions; (ii) a polypeptide dihydropteroate synthase activity having a defined sequence of 285 amino acids given in the specification, optionally with one or more amino acid deletions, insertions or substitutions; (iii) a polypeptide with dihydroneopterin aldolase activity having a defined sequence of 131 amino acids given in the specification, optionally with one or more amino acid deletions, insertions or substitutions; and (iv) a polypeptide with 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase activity having a defined sequence of 160 amino acids given in the specification, optionally with one or more amino acid deletions, insertions or substitutions. Independent claims are also included for the following: (1) a polynucleotide encoding one of the polypeptides; (2) a gene construct comprising at least one copy of the polynucleotide of (1) together with at least one regulatory sequence; (3) a host organism transformed with the gene construct of (2); (4) production of folic acid by culturing the organism of (3).
机译:谷氨酸棒杆菌GTP环水解酶I,二氢蝶呤合酶,二氢蝶呤醛缩酶和2-氨基-4-羟基-6-羟甲基-二氢蝶呤焦磷酸激酶多肽是新的。下列多肽是新的:(i)具有GTP环水解酶I活性的多肽,具有本说明书中给出的202个氨基酸的限定序列,可选地具有一个或多个氨基酸的缺失,插入或取代; (ii)具有说明书中给出的285个氨基酸的限定序列,任选具有一个或多个氨基酸缺失,插入或取代的多肽二氢蝶呤合酶活性; (iii)具有双氢蝶呤醛缩酶活性的多肽,具有在说明书中给出的131个氨基酸的限定序列,任选地具有一个或多个氨基酸的缺失,插入或取代; (iv)具有2-氨基-4-羟基-6-羟甲基-二氢蝶呤焦磷酸激酶活性的多肽,具有在说明书中给出的160个氨基酸的限定序列,任选地具有一个或多个氨基酸的缺失,插入或取代。还包括以下方面的独立权利要求:(1)编码一种多肽的多核苷酸; (2)一种基因构建体,其包含(1)的多核苷酸的至少一个拷贝以及至少一个调节序列; (3)用(2)的基因构建体转化的宿主生物; (4)通过培养(3)的生物来生产叶酸。

著录项

  • 公开/公告号DE19929363A1

    专利类型

  • 公开/公告日2000-12-28

    原文格式PDF

  • 申请/专利权人 BASF-LYNX BIOSCIENCE AG;

    申请/专利号DE1999129363

  • 发明设计人 MACK MATTHIAS;HERBSTER KARIN;

    申请日1999-06-25

  • 分类号C07K14/34;C12N15/77;C12N1/21;

  • 国家 DE

  • 入库时间 2022-08-22 01:10:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号